Unlocking Neuroprotection and Anti-Inflammation: A Deep Dive into ARA-290 Peptide (Cibinetide)
Discover the potent therapeutic potential of Cibinetide, a groundbreaking peptide for enhanced tissue repair and reduced inflammation.
Get a Quote & SampleProduct Core Value
Neuroprotective Peptide 1208243-50-8
Cibinetide, also known as ARA-290, is a synthetic peptide that acts as a selective agonist for the Innate Repair Receptor (IRR). Unlike its parent molecule, Erythropoietin (EPO), Cibinetide does not stimulate red blood cell production, thereby avoiding associated side effects. Its primary benefit lies in its ability to dampen innate immune cell functions and initiate local anti-inflammatory responses, preventing overt tissue damage.
- Explore the potential of ARA-290 peptide for anti-inflammation in various therapeutic applications, offering a novel approach to managing inflammatory conditions.
- Understand the detailed mechanisms behind cibinetide neuroprotective effects, highlighting its role in protecting nerve cells from damage.
- Learn about the advancements in peptide therapy for colitis, showcasing how Cibinetide ameliorates symptoms and improves tissue integrity.
- Discover how this EPO derivative is being utilized for pain relief, offering long-term analgesia for conditions like neuropathic pain.
Advantages Provided by the Product
Targeted Anti-Inflammatory Action
Cibinetide's unique mechanism of action targets innate immune cells, offering a precise way to manage inflammation without broad immunosuppression, thus supporting the goal of ARA-290 peptide for anti-inflammation.
Enhanced Neuroprotection
The peptide exhibits significant neuroprotective qualities, making it a key player in developing treatments for neurological disorders and nerve damage, aligning with research into cibinetide neuroprotective effects.
Reduced Side Effect Profile
By focusing on the Innate Repair Receptor (IRR), Cibinetide offers the therapeutic benefits of EPO-like signaling without the erythropoietic effects, presenting a safer option for patients and supporting its application in peptide therapy for colitis.
Key Applications
Inflammatory Conditions Management
Leveraging its ARA-290 peptide for anti-inflammation properties, Cibinetide is being investigated for conditions like inflammatory bowel disease, aiming to reduce disease activity and improve patient outcomes.
Neurological Health Support
The study of cibinetide neuroprotective effects suggests its utility in protecting nerve cells and treating neuropathic pain, potentially offering new avenues for patient care.
Advanced Wound Healing
Research indicates that Cibinetide may play a role in stimulating wound repair, particularly in patients with chronic conditions like diabetes, contributing to the broader understanding of peptide therapy for colitis and related healing processes.
Pain Management Therapies
As an EPO derivative for pain relief, Cibinetide's analgesic properties are being explored for chronic pain conditions, offering a targeted approach to symptom management.